Delivery Order SPE2DR25D9316-SPE2DR26FSCA4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, was not set aside for any particular business category. DMS Pharmaceutical Group will perform under this order from...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). The award, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the vendor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $49,586.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 28, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the award was made through full and open competition. The contract is funded by the...
- The Defense Logistics Agency awarded a $12,364.81 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The award, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, carries no set-aside designation and utilizes firm fixed-price pricing. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency issued a delivery order valued at $12,338.41 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 20 mg, a firm fixed-price pharmaceutical procurement with an ultimate completion date of December 10, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received this award without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency has awarded a $33,240.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). The delivery order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency awarded a $24,729.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for supply of Jakafi 10 mg tablets (60-count units). The delivery order, issued on November 28, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $24,493.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 15 mg tablets (60-count). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and was awarded on November 18, 2025. This award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 20, 2025, with an ultimate completion date of November 21, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60 count). The award, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the vendor competed in an unrestricted procurement. This delivery...
- SPE2DR25D9316Indefinite Delivery Contract
- SPE2DR25D9316-SPE2DR26FSCA4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $37,495.66 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 10 mg on December 2, 2025, with an ultimate completion date of December 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The delivery order is to be fulfilled at the contractor's location in Park Ridge, Illinois, and represents a single shipment of this oncology/hematology medication to support Department of Defense medical supply requirements. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036. The PPV-G GEN V program is a $30.3 billion acquisition strategy establishing multiple regional prime vendor contractors to supply comprehensive pharmaceutical products and medical consumables to military healthcare facilities worldwide. As one of several approved vendors under this framework, DMS Pharmaceutical Group has demonstrated consistent performance delivering diverse pharmaceutical products including branded and generic medications, biologics, vaccines, and specialty pharmaceuticals across multiple delivery orders issued by the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.5k | 12/1/25 |